Creative Planning’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.11M Buy
53,289
+17,167
+48% +$678K ﹤0.01% 1271
2025
Q1
$1.09M Sell
36,122
-10,681
-23% -$322K ﹤0.01% 1648
2024
Q4
$1.64M Buy
46,803
+18,421
+65% +$644K ﹤0.01% 1264
2024
Q3
$1.14M Buy
28,382
+1,522
+6% +$61K ﹤0.01% 1423
2024
Q2
$1.28M Sell
26,860
-145
-0.5% -$6.91K ﹤0.01% 1240
2024
Q1
$1.17M Buy
27,005
+1,706
+7% +$74K ﹤0.01% 1229
2023
Q4
$1.28M Buy
25,299
+3,727
+17% +$189K ﹤0.01% 1107
2023
Q3
$979K Buy
21,572
+6,329
+42% +$287K ﹤0.01% 1167
2023
Q2
$625K Buy
15,243
+1,611
+12% +$66.1K ﹤0.01% 1410
2023
Q1
$487K Buy
13,632
+204
+2% +$7.29K ﹤0.01% 1480
2022
Q4
$507K Sell
13,428
-464
-3% -$17.5K ﹤0.01% 1410
2022
Q3
$614K Buy
13,892
+1,163
+9% +$51.4K ﹤0.01% 1194
2022
Q2
$471K Sell
12,729
-29
-0.2% -$1.07K ﹤0.01% 1350
2022
Q1
$472K Sell
12,758
-2,358
-16% -$87.2K ﹤0.01% 1349
2021
Q4
$460K Buy
15,116
+201
+1% +$6.12K ﹤0.01% 1356
2021
Q3
$500K Buy
14,915
+1,595
+12% +$53.5K ﹤0.01% 1291
2021
Q2
$531K Sell
13,320
-30,859
-70% -$1.23M ﹤0.01% 1244
2021
Q1
$1.99M Buy
44,179
+8,739
+25% +$393K ﹤0.01% 721
2020
Q4
$2M Sell
35,440
-47
-0.1% -$2.66K ﹤0.01% 665
2020
Q3
$1.68M Buy
35,487
+16,201
+84% +$769K ﹤0.01% 612
2020
Q2
$1.14M Buy
19,286
+40
+0.2% +$2.36K ﹤0.01% 694
2020
Q1
$910K Sell
19,246
-1,805
-9% -$85.3K ﹤0.01% 681
2019
Q4
$1.27M Sell
21,051
-2,234
-10% -$135K ﹤0.01% 675
2019
Q3
$1.4M Buy
23,285
+552
+2% +$33.1K ﹤0.01% 617
2019
Q2
$1.46M Buy
22,733
+106
+0.5% +$6.81K ﹤0.01% 600
2019
Q1
$1.84M Sell
22,627
-4,808
-18% -$390K 0.01% 491
2018
Q4
$1.48M Buy
27,435
+817
+3% +$44.2K 0.01% 505
2018
Q3
$1.37M Buy
26,618
+2,320
+10% +$120K 0.01% 614
2018
Q2
$1.01M Buy
24,298
+611
+3% +$25.4K ﹤0.01% 736
2018
Q1
$1.04M Sell
23,687
-1,679
-7% -$74K ﹤0.01% 711
2017
Q4
$1.28M Sell
25,366
-137
-0.5% -$6.89K 0.01% 595
2017
Q3
$1.29M Sell
25,503
-996
-4% -$50.5K 0.01% 599
2017
Q2
$1.35M Sell
26,499
-357
-1% -$18.2K 0.01% 562
2017
Q1
$1.08M Buy
26,856
+1,442
+6% +$58K 0.01% 634
2016
Q4
$1.22M Sell
25,414
-801
-3% -$38.3K 0.01% 557
2016
Q3
$961K Sell
26,215
-252
-1% -$9.24K 0.01% 607
2016
Q2
$616K Buy
26,467
+5,991
+29% +$139K ﹤0.01% 688
2016
Q1
$829K Sell
20,476
-2,217
-10% -$89.8K 0.01% 556
2015
Q4
$1.41M Buy
22,693
+989
+5% +$61.2K 0.01% 401
2015
Q3
$877K Buy
21,704
+3,018
+16% +$122K 0.01% 514
2015
Q2
$1.08M Buy
18,686
+6,982
+60% +$402K 0.01% 445
2015
Q1
$745K Sell
11,704
-8,050
-41% -$512K 0.01% 567
2014
Q4
$1.22M Buy
19,754
+10,492
+113% +$648K 0.01% 390
2014
Q3
$360K Sell
9,262
-11,396
-55% -$443K ﹤0.01% 784
2014
Q2
$712K Buy
20,658
+14,790
+252% +$510K 0.01% 508
2014
Q1
$254K Buy
5,868
+248
+4% +$10.7K ﹤0.01% 887
2013
Q4
$224K Buy
5,620
+3,467
+161% +$138K ﹤0.01% 816
2013
Q3
$81K Buy
2,153
+1,500
+230% +$56.4K ﹤0.01% 1244
2013
Q2
$18K Buy
+653
New +$18K ﹤0.01% 1996